- Eli Lilly Stock Rises on Earnings and Boost to Guidance Barron’s
- Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar CNBC
- Eli Lilly raises full-year forecast, as weight-loss drugs demand drives third-quarter beat Yahoo Finance
- Lilly Raises Guidance on Strength of Weight Loss, Obesity Drugs Bloomberg
- Eli Lilly stock pops on raised full-year outlook (LLY:NYSE) Seeking Alpha
Source link
